Medicine Description microgenest 0.3 /0.15 mg
microgenest 21 tablets is a medication designed for oral contraception. Its primary active ingredient, ethinyl estradiol, operates synergistically with its partner component to inhibit the hypothalamic release of gonadotropin-releasing hormone (GnRH), leading to a reduction in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels. By suppressing these hormones, ovulation is prevented. Additionally, ethinyl estradiol induces changes in the cervical mucus, enhancing its viscosity, which serves as a barrier to sperm migration. Furthermore, it alters the endometrial lining, making it less receptive to a fertilized ovum. Collectively, these actions create an effective mechanism for preventing pregnancy.
Indications and Uses of microgenest 21 tablets
- Prevention of pregnancy in women of reproductive age.
- Management of menstrual disorders associated with hormonal imbalance.
- Treatment of conditions such as endometriosis and polycystic ovary syndrome (PCOS).
- Regulation of menstrual cycles for those with irregular periods.
Side Effects of microgenest 21 tablets
- Nausea and vomiting.
- Headaches or migraines.
- Breast tenderness or swelling.
- Changes in weight or appetite.
- Spotting or breakthrough bleeding between menstrual cycles.
- Emotional fluctuations such as mood swings.
Storage and Handling
Microgenest 21 tablets should be stored in a cool, dry place away from direct light and moisture. Keep out of reach of children and do not use after the expiration date printed on the packaging.
Patient Advice and Precautions
Patients are advised to take Microgenest 21 tablets at the same time each day for optimal effectiveness. It is essential to discuss any history of blood clots, liver disease, or other significant medical conditions with a healthcare provider before starting this medication. Regular check-ups should be scheduled to monitor health and discuss any side effects experienced during treatment.